Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation.

Rafati, Sima

Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation. [electronic resource] - Vaccine Jun 2002 - 2439-47 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0264-410X

10.1016/s0264-410x(02)00189-5 doi


Animals
CD8-Positive T-Lymphocytes--immunology
Cysteine Endopeptidases--administration & dosage
Female
Interferon-gamma--biosynthesis
Leishmania major--immunology
Leishmaniasis--prevention & control
Lymphocyte Activation--immunology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Protozoan Vaccines--administration & dosage
Recombinant Proteins--administration & dosage